Product Description
        Ref-SKU:      
        007N-05792  full length plasmid clone of proviral HIV-1; construct produces fully infectious HIV-1 upon transfection into eukaryotic cells; based on NL-BX
Product Risk Group: 
Information on the related virus
ICTV Taxonomy: 
Virus name: 
Strain: 
Isolate: 
Cloned Product: Yes
Can it be used to produce GMO: 
No
Biosafety restrictions: 
Upon transfection of eukaryotic cells DNA can produce infectious virus causing disease in humans 
Region encompassed in this Product: 
entire genome
Plasmid: 
Plasmid selection: 
TAG: 
Sequencing: 
Fully sequenced
Sequence checked: 
Yes
Mutations: 
Contain mutations (no frameshift, no unexpected STOP codon)
Observed mutations: 
mutation as indicated in the name; backbone is NL-BX:
The virus genome is derived from pNL-NF (pNL4-3 with shortened cellular flank) (doi.org/10.1016/j.jcv.2006.05.001), after introduction of a unique BamHI site 5’ (ggagcc2207ggaTcc; A->S in Pol; E->D in Gag) and an XmaI site 3’ (ccagga2589ccCggG; silent in Env; L->S in Rev) from the protease gene, respectively. The original BamHI site as position 8465 was removed (GGATCC->GGATCA change);
carries a C2575T mutation = P9S in RT
.gb file of the construct: 
Identification technique: 
restriction digest (Hind III), partial sequencing
Nucleic Acid preparation technique: 
solid phase column extraction
Storage conditions: 
TE Buffer -20C
Shipping conditions: 
IATA Classification: 
Virus host type: 
Special feature: 
Information about the origin of the product
Recombinant product: 
This product is a recombinant product
Biological material origin: 
Synthetic origin & Natural origin
Natural part identification: derived from the proviral clone NL4-3
Natural part identification: 
derived from the proviral clone NL4-3
Genbank reference: 
Collection date: BEFORE 
Friday, 1 January, 2010
Country of collection: 
Synthetic part identification: based on NL4-3 sequence
Synthetic part identification: 
based on NL4-3 sequence
Modifications from the reference sequence(s): 
The sequence(s) of this synthetic product has been modified from the sequence listing provided as Genbank references
Description of modification(s) made from the reference sequence(s): 
PCR-based mutagenesis; carries the indicated mutation(s) in the target gene as shown in the product name
